Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Limbitrol (amitriptyline plus chlordiazepoxide) revisited.

Psychopharmacology

|January 1, 1981

Summary

This summary is machine-generated.

Limbitrol demonstrated superior efficacy over amitriptyline (AT) for highly depressed patients with anxiety. This advantage persisted for a significant subgroup after 4 weeks of treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Replication Of Symptom Distress Factors In Anxious Neurotic Outpatients.

Multivariate behavioral research·2016

Same author

Re: Over-the-counter drugs for the treatment of mood and anxiety disorders--the views of German pharmacists. By J. Hamann, K. Linde, H. D. Schweiger, O. Kusmakow, H. Foerstl, Pharmacopsychiatry 2014; 47: 84-88.

Pharmacopsychiatry·2014

Same author

Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.

The pharmacogenomics journal·2012

Same author

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.

The pharmacogenomics journal·2011

Same author

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.

The American journal of psychiatry·2001

Same author

Venlafaxine in the treatment of premenstrual dysphoric disorder.

Obstetrics and gynecology·2001

Area of Science:

Psychiatry
Clinical Pharmacology

Background:

Depression and anxiety often co-occur, complicating treatment.
Previous studies have evaluated various antidepressant medications.

Purpose of the Study:

To reanalyze data on Limbitrol versus amitriptyline (AT) in depressed patients.
To assess treatment differences in subgroups based on illness severity and anxiety levels.

Main Methods:

Reanalysis of 4-week treatment data from Feighner et al. (1979).
Comparison of Limbitrol and AT efficacy in distinct patient subgroups.

Main Results:

Limbitrol showed significant advantages over AT in highly depressed patients with moderate anxiety at 1, 2, and 4 weeks.
Amitriptyline was slightly favored in less severely ill patients.

Related Experiment Videos

Conclusions:

Limbitrol is more effective than AT for heterogeneous depressed patients with anxiety, particularly in early treatment phases.
Limbitrol maintains superior efficacy over AT for a subgroup of severely depressed patients after 4 weeks.